NCT06944470 2025-04-25JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLCShanghai Junshi Bioscience Co., Ltd.Phase 2 Not yet recruiting76 enrolled
NCT06672068 2024-12-30A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLCTYK Medicines, IncPhase 2 Not yet recruiting60 enrolled